Sept 26 (Reuters) - Pfizer Inc on Monday submitted an application to the U.S. Food and Drug Administration (FDA) requesting the authorization of an Omicron-specific COVID-19 vaccine booster for children aged 5 through 11 years. (Reporting by Leroy Leo in Bengaluru; Editing by Savio D'Souza)